Innoventis Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-11-2024
- Paid Up Capital ₹ 0.50 M
as on 04-11-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Ebitda
- Net Worth -2.63%
(FY 2023)
- Total Assets %
(FY 2023)
About Innoventis Medicare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Preeti Lohariwala, Rahul Luhariwala, Archit Aggarwal, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24100HR2020PLC086760
- Company No.
086760
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2020
- Date of AGM
01 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Innoventis Medicare?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preeti Lohariwala  | Director | 13-Jun-2022 | Current |
| Rahul Luhariwala | Director | 13-Jun-2022 | Current |
| Archit Aggarwal | Director | 03-Aug-2020 | Current |
| Rohit Lohariwala | Director | 13-Jun-2022 | Current |
| Vinay Lohariwala | Director | 13-Jun-2020 | Current |
| Manoj Lohariwala | Director | 13-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Innoventis Medicare.
Innoventis Medicare Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 2.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Innoventis Medicare?
In 2023, Innoventis Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Univentis Medicare LimitedActive 9 years 5 monthsVinay Lohariwala and Manoj Lohariwala are mutual person
Nugenic Pharma Private LimitedActive 20 years 11 daysRahul Luhariwala, Rohit Lohariwala and 2 more are mutual person
- Innova Captab LimitedActive 19 years 11 months
Archit Aggarwal, Vinay Lohariwala and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innoventis Medicare?
Innoventis Medicare has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innoventis Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innoventis Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
